Healthcare
Health
Medical

LabCorp

$152.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.40 (-0.91%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell LabCorp and other stocks, options, ETFs, and crypto commission-free!

About

Laboratory Corporation of America Holdings, also called LabCorp, is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. Read More The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment involves in providing drug development solutions, to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

Employees
61,000
Headquarters
Burlington, North Carolina
Founded
1971
Market Cap
15.26B
Price-Earnings Ratio
17.77
Dividend Yield
0.00
Average Volume
811.07K
High Today
$153.88
Low Today
$152.09
Open Price
$153.63
Volume
172.79K
52 Week High
$190.36
52 Week Low
$119.38

Collections

Healthcare
Health
Medical
Pharmaceutical
Biotechnology
US
North America

News

TradingNewsNow20h

Latest Change: Laboratory Corporation Of America (NYSE: LH)

Laboratory Corporation Of America trades as part of the medical diagnostics and research industry and is in the healthcare sector.

3
Yahoo FinanceMar 12

How Do Analysts See Laboratory Corporation of America Holdings (NYSE:LH) Performing In The Next 12 Months?

As Laboratory Corporation of America Holdings (NYSE:LH) announced its earnings release on 31 December 2018, analyst forecasts seem fairly subdued, with profits predicted to rise by 3.6% next year against the higher past 5-year average growth rate of 22%. Currently with trailing-twelve-month earnings of US$884m, we can expect this to reach US$915m by 2020. Below is a brief commentary on the longer term outlook the market has for Laboratory of America Holdings.

14
Yahoo FinanceMar 12

See what the IHS Markit Score report has to say about Laboratory Corporation of America Holdings.

View full report here! Bearish sentiment Short interest | Positive Short interest is extremely low for LH with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting LH. Money flow ETF/Index ownership | Neutral ETF activity is neutral. ETFs that hold LH had net inflows of $3.95 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic...

13

Earnings

$2.38
$2.58
$2.78
$2.98
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 24, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.